Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

BACKGROUND: The present study aimed to evaluate the suppressive role of interleukin (IL)-25 in IL-22-induced osteoclastogenesis and receptor activator of nuclear factor κB ligand (RANKL) expression in rheumatoid arthritis (RA). METHODS: Serum from patients with RA and osteoarthritis (OA), and health...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Hong Ki, Won, Ji-Yeon, Kim, Bo-Mi, Lee, Kyung-Ann, Lee, Seoung-Joon, Lee, Sang-Heon, Kim, Hae-Rim, Kim, Kyoung-Woon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517649/
https://www.ncbi.nlm.nih.gov/pubmed/32972460
http://dx.doi.org/10.1186/s13075-020-02315-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517649/
https://www.ncbi.nlm.nih.gov/pubmed/32972460
http://dx.doi.org/10.1186/s13075-020-02315-8

Ejemplares similares